白血病分子诊断技术咸阳.pptxVIP

白血病分子诊断技术;WH0血液肿瘤分类方案（1999年）;WH0血液肿瘤分类方案（2008年）;白血病分子诊断的意义;WHO血液肿瘤新分类实验技术平台;基因检测 ——融合基因 基因突变;“二次打击”学说;CML Indications for Diagnostic Tests Milestones and Monitoring in Patients with CML Treated with Imatinib (2008 ASH Education Program Book p420) Test Indication Physical Exam Diagnosis/Staging Every three month until resolution of splenomegaly Suspected progression or resistance Complete Blood Count Diagnosis/Staging Every 1-2 weeks until blood count have stabilized, then at 6 w